U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C7H14N2O3
Molecular Weight 174.1977
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THEANINE

SMILES

CCNC(=O)CC[C@H](N)C(O)=O

InChI

InChIKey=DATAGRPVKZEWHA-YFKPBYRVSA-N
InChI=1S/C7H14N2O3/c1-2-9-6(10)4-3-5(8)7(11)12/h5H,2-4,8H2,1H3,(H,9,10)(H,11,12)/t5-/m0/s1

HIDE SMILES / InChI

Molecular Formula C7H14N2O3
Molecular Weight 174.1977
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

L-Theanine is a relaxing and nondietary amino acid found pretty much exclusively in teas from Camellia sinensis (alongside green tea catechins and caffeine) and is known to promote relaxation without sedation. It appears to be effective at this as well as reducing stress at standard dosages. L-theanine was discovered as a constituent of green tea in 1949 and was approved in Japan in 1964 for unlimited use in all foods, including chocolates, soft drinks, and herb teas, except infant foods. It also provides a unique umami (brothy or savory) taste and flavor to green tea infusion. L-theanine may help relieve stress by inducing a relaxing effect without drowsiness and may also possess immunologic attributes. Theanine may also have effects on the cardiovascular system and play a preventative role in cancer; however, limited clinical information is available to support these claims. L-Theanine and its positive effects on cognitive performance is one of its most important functions. Because of chemical structure of L-Theanine similar to glutamate it can act as a neurotransmitter related to memory. In a study made on rats, it was found out that L-Theanine modulated the serotonin and dopamine levels and increased learning skills with memory. In addition, it is stated that L-Theanine increases neuro - throphine mRNA level by activating its neuro - transmitter inhibiting system and supports the central nervous system that helps the development of brain functions. L-Theanine had a positive effect on memory and had positive effects on the treatment and prevention of Alzheimer. Theanine is an antagonist of the NMDA receptors (albeit with fairly weak efficacy) and can inhibit synaptic release of glutamate via blocking the transporter competitively. Theanine may also reduce glutamate levels, but this is also a fairly weak mechanism requiring a high concentration of theanine.

CNS Activity

Curator's Comment: Orally administered L-Theanine supplementation is able to cross the blood brain barier.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
ZEN THEANINE

Approved Use

ZEN THEANINE is used to provide fast-acting mental relaxation, with its stress reducing effects typically felt within 30 minutes of consumption.
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
24.3 μM
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THEANINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
2.8 μM
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THEANINE red blood cells
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
43.1 μM
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
GLUTAMIC ACID red blood cells
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
12.9 μM
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
GLUTAMIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
6.1 μM
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ETHYLAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
57.1 μM × h
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THEANINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
50.5 μM × h
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THEANINE red blood cells
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
276 μM × h
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
GLUTAMIC ACID red blood cells
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
38.9 μM × h
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
GLUTAMIC ACID plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
101 μM × h
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
ETHYLAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
1.2 h
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THEANINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
Doses

Doses

DosePopulationAdverse events​
900 mg 1 times / day multiple, oral
Highest studied dose
Dose: 900 mg, 1 times / day
Route: oral
Route: multiple
Dose: 900 mg, 1 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways.
2009-12-01
The effect of taurine, a novel biochemical modulator, on the antitumor activity of doxorubicin.
2009-09
Ethylamine content and theanine biosynthesis in different organs of Camellia sinensis seedlings.
2009-08-15
Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma.
2009-08
Bioactive components of tea: cancer, inflammation and behavior.
2009-08
Impact of two types of Internet-based information on medical students' performance in an Objective Structured Clinical Exam (OSCE).
2009-07
Changes in the composition of raw tea leaves from the Korean Yabukida plant during high-temperature processing to pan-fried Kamairi-cha green tea.
2009-06
The effects of L-theanine on alpha-band oscillatory brain activity during a visuo-spatial attention task.
2009-06
Effects of oral supplementation with cystine and theanine on the immune function of athletes in endurance exercise: randomized, double-blind, placebo-controlled trial.
2009-04-23
Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells.
2009-04
Rat electropharmacograms of the flavonoids rutin and quercetin in comparison to those of moclobemide and clinically used reference drugs suggest antidepressive and/or neuroprotective action.
2009-04
Tea and health: preventive and therapeutic usefulness in the elderly?
2009-01
Theanine, gamma-glutamylethylamide, a unique amino acid in tea leaves, modulates neurotransmitter concentrations in the brain striatum interstitium in conscious rats.
2009-01
Aqueous fish extract increases survival in the mouse model of cytostatic toxicity.
2008-12-04
Co-administration of l-cystine and l-theanine enhances efficacy of influenza vaccination in elderly persons: nutritional status-dependent immunogenicity.
2008-12
L-theanine elicits an umami taste with inosine 5'-monophosphate.
2008-11
Determination of theanine, GABA, and other amino acids in green, oolong, black, and Pu-erh teas with dabsylation and high-performance liquid chromatography.
2008-09-10
[Determination of hydroxyproline in collagenous proteins by high performance liquid chromatography-mass spectrometry].
2008-09
[The effect of theanine on oxygen-induced retinal neovascularization in the neonatal rat].
2008-08
The combined effects of L-theanine and caffeine on cognitive performance and mood.
2008-08
Immobilization of Escherichia coli novablue gamma-glutamyltranspeptidase in Ca-alginate-kappa-carrageenan beads.
2008-08
Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death.
2008-07
Theanine, an ingredient of green tea, inhibits [3H]glutamine transport in neurons and astroglia in rat brain.
2008-06
Theanine production by coupled fermentation with energy transfer using gamma-glutamylmethylamide synthetase of Methylovorus mays No. 9.
2008-05
Administration of theanine, a unique amino acid in tea leaves, changed feeding-relating components in serum and feeding behavior in rats.
2008-05
Effects of theanine, a unique amino acid in tea leaves, on memory in a rat behavioral test.
2008-05
Altered levels of oxidation and phospholipase C isozyme expression in the brains of theanine-administered rats.
2008-05
Effect of green tea and (-)-epigallocatechin gallate on ethanol-induced toxicity in HepG2 cells.
2008-05
L-theanine intervention enhances human gammadeltaT lymphocyte function.
2008-02
Psychological effects of dietary components of tea: caffeine and L-theanine.
2008-02
The effects of L-theanine, caffeine and their combination on cognition and mood.
2008-02
Cloning and expression of Methylovorus mays No. 9 gene encoding gamma-glutamylmethylamide synthetase: an enzyme usable in theanine formation by coupling with the alcoholic fermentation system of baker's yeast.
2008-01
Time for tea: mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together.
2008-01
Theanine prevents memory impairment induced by repeated cerebral ischemia in rats.
2008-01
L-theanine, a natural constituent in tea, and its effect on mental state.
2008
Enhancement of antigen-specific immunoglobulin G production in mice by co-administration of L-cystine and L-theanine.
2007-12
Source density analysis of the human EEG after ingestion of a drink containing decaffeinated extract of green tea enriched with L-theanine and theogallin.
2007-11-21
A soothing sip of focus. The latest on tea: it might quiet distracted minds.
2007-10-08
[Effects of theanine and houpu extract in 7-day chick social separation-stress procedure].
2007-10
Involvement of GABA(A) receptors in the neuroprotective effect of theanine on focal cerebral ischemia in mice.
2007-10
Theogallin and L-theanine as active ingredients in decaffeinated green tea extract: II. Characterization in the freely moving rat by means of quantitative field potential analysis.
2007-10
Theanine, r-glutamylethylamide, increases neurotransmission concentrations and neurotrophin mRNA levels in the brain during lactation.
2007-09-29
Determination of amino acids in tea leaves and beverages using capillary electrophoresis with light-emitting diode-induced fluorescence detection.
2007-09-15
[Separation and quantification of theanine enantiomers using high performance liquid chromatography coupled with chiral derivatization].
2007-09
Theogallin and L-theanine as active ingredients in decaffeinated green tea extract: I. electrophysiological characterization in the rat hippocampus in-vitro.
2007-08
Differentiation of green, white, black, Oolong, and Pu-erh teas according to their free amino acids content.
2007-07-25
Effects of green tea fractions on oxygen-induced retinal neovascularization in the neonatal rat.
2007-07
[Determination of amino acids in tea samples by capillary electrophoresis with partition cell and indirect ultraviolet detection].
2007-03
Spontaneous renal tubular hyperplastic and neoplastic lesions in three Sprague-Dawley rats from a 90-day toxicity study.
2007-02
Inhibitory effects of theanine and sera from theanine-fed rats on receptor-mediated cancer cell invasion beneath mesothelial-cell monolayers.
2001-07
Patents

Sample Use Guides

In Vivo Use Guide
Studies reporting an anti-anxiety effect used single doses of theanine 200 to 250 mg.
Route of Administration: Oral
Theanine promoted DC secretion of IL-12. IL-12 levels reached (137.4 ± 4.9) pg/ml with theanine at 200 umol/L. However, theanine inhibited the secretion of IL-10 in a dose-dependent manner. IL-10 levels were only (58.4 ± 6.9) pg/ml with theanine at 200 umol/L.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:22:00 GMT 2025
Edited
by admin
on Mon Mar 31 18:22:00 GMT 2025
Record UNII
8021PR16QO
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
THEANINE
INCI   MI   VANDF   WHO-DD  
INCI  
Official Name English
L-THEANINE
USP-RS  
Preferred Name English
L-THEANINE [USP-RS]
Common Name English
THEANINE [MI]
Common Name English
N-ETHYL-L-GLUTAMINE
Systematic Name English
Theanine [WHO-DD]
Common Name English
THEANINE [VANDF]
Common Name English
THEANINE, L-
Systematic Name English
NSC-21308
Code English
Classification Tree Code System Code
DSLD 607 (Number of products:983)
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
221-379-0
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
SMS_ID
100000126208
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
GRAS Notification (GRN No.)
338
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
NSC
21308
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
MESH
C026166
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
NCI_THESAURUS
C87348
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
EPA CompTox
DTXSID80184817
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
RXCUI
38022
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY RxNorm
CHEBI
17394
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
NCI_THESAURUS
C1505
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
CONCEPT Dietary Supplement
RS_ITEM_NUM
1652704
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
WIKIPEDIA
THEANINE
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
EVMPD
SUB33407
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
MERCK INDEX
m10694
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY Merck Index
DAILYMED
8021PR16QO
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
GRAS Notification (GRN No.)
209
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
HSDB
8166
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
EVMPD
SUB33692
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
FDA UNII
8021PR16QO
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
PUBCHEM
439378
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
CHEBI
58128
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
GRAS Notification (GRN No.)
501
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
CAS
3081-61-6
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
DRUG BANK
DB12444
Created by admin on Mon Mar 31 18:22:00 GMT 2025 , Edited by admin on Mon Mar 31 18:22:00 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
PARENT -> CONSTITUENT ALWAYS PRESENT
Related Record Type Details
ACTIVE MOIETY